Key Takeaways from Exploring Best Practices for Biopharma DTP Implementation – Part 2 ixlayer’s recent webinar in collaboration with The DHC Group, Exploring Best Practices for Biopharma DTP Implementation, clarifies
Key Takeaways from Exploring Best Practices for Biopharma DTP Implementation – Part 1 ixlayer’s recent webinar in collaboration with The DHC Group, Exploring Best Practices for Biopharma DTP Implementation, clarifies
ixlayer is Recognized as a Premiere Patient Engagement Startup and Named to the 2025 New York Digital Health 100 ixlayer is a top 100 healthcare company powering direct-to-patient platforms for
This article was originally published in Pharmaceutical Executive. Engaging Patients: Why Pharma’s Direct-to-Patient Approach Should Be Applauded Physicians remain central even as DTP programs are implemented. Pharmaceutical companies’ direct-to-patient (DTP)
IX Layer Inc.
447 Sutter Street, Suite 405, PMB 53
San Francisco, CA 94108
IX Layer Inc.
222 Broadway, 22nd Floor
New York, NY 10038
